Cargando…

Interleukin-6 and severe COVID-19: a systematic review and meta-analysis

BACKGROUND: Evidence links COVID-19 severity to hyper-inflammation. Treatment with tocilizumab, a monoclonal antibody directed against the interleukin-6 (IL-6) receptor, was shown to lead to clinical improvement in patients with severe COVID-19. We, therefore, performed the present systematic review...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mojtabavi, Helia, Saghazadeh, Amene, Rezaei, Nima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Libbey Eurotext 2020
Materias:	Short Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530350/ https://www.ncbi.nlm.nih.gov/pubmed/32933891 http://dx.doi.org/10.1684/ecn.2020.0448

Ejemplares similares

Peripheral blood levels of brain-derived neurotrophic factor in patients with post-traumatic stress disorder (PTSD): A systematic review and meta-analysis
por: Mojtabavi, Helia, et al.
Publicado: (2020)

Computed tomography scan in COVID-19: a systematic review and meta-analysis
por: Sharif, Pouya Mahdavi, et al.
Publicado: (2022)

Vascular endothelial growth factor levels in tuberculosis: A systematic review and meta-analysis
por: Saghazadeh, Amene, et al.
Publicado: (2022)

A systematic review of pregnant women with COVID-19 and their neonates
por: Mirbeyk, Mona, et al.
Publicado: (2021)

Evaluating COVID-19–Environment Fit
por: Saghazadeh, Amene, et al.
Publicado: (2022)

Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review
por: Mohamed, Kawthar, et al.
Publicado: (2021)

Biosensing surfaces and therapeutic biomaterials for the central nervous system in COVID-19
por: Saghazadeh, Amene, et al.
Publicado: (2021)

Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies
por: Saleki, Kiarash, et al.
Publicado: (2021)

Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids
por: Saghazadeh, Amene, et al.
Publicado: (2020)

Brain-derived neurotrophic factor in diabetes mellitus: A systematic review and meta-analysis
por: Moosaie, Fatemeh, et al.
Publicado: (2023)

Altered immunoemotional regulatory system in COVID-19: From the origins to opportunities
por: Pourriyahi, Homa, et al.
Publicado: (2021)

Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis
por: Agah, Elmira, et al.
Publicado: (2018)

Circulating brain-derived neurotrophic factor as a potential biomarker in stroke: a systematic review and meta-analysis
por: Mojtabavi, Helia, et al.
Publicado: (2022)

CSF and blood biomarkers in amyotrophic lateral sclerosis: protocol for a systematic review and meta-analysis
por: Agah, Elmira, et al.
Publicado: (2018)

TIM family gene polymorphism and susceptibility to rheumatoid arthritis: Systematic review and meta-analysis
por: Razi, Bahman, et al.
Publicado: (2019)

Cognitive Biases Affecting the Maintenance of COVID-19 Pandemic
por: Mohamed, Kawthar, et al.
Publicado: (2021)

Potential Prophylactic and Therapeutic Effects of Respiratory Physiotherapy for COVID-19
por: Shakerian, Narges, et al.
Publicado: (2021)

The prevalence of post-traumatic stress disorder related symptoms in Coronavirus outbreaks: A systematic-review and meta-analysis
por: Salehi, Mona, et al.
Publicado: (2021)

Pulmonary Manifestations of Predominantly Antibody Deficiencies
por: Saghazadeh, Amene, et al.
Publicado: (2019)

The Physical Burden of Immunoperception
por: Saghazadeh, Amene, et al.
Publicado: (2019)

Poxviruses and the immune system: Implications for monkeypox virus
por: Saghazadeh, Amene, et al.
Publicado: (2022)

An overview of possible solutions putting an end to the COVID-19 pandemic
por: Adiban Afkham, Saina, et al.
Publicado: (2022)

Clinical safety and efficacy of bispecific antibody in the treatment of solid tumors: A protocol for a systematic review
por: Nejadghaderi, Seyed Aria, et al.
Publicado: (2022)

Nanotechnology-based diagnostics and therapeutics in acute lymphoblastic leukemia: a systematic review of preclinical studies
por: Khademi, Reyhane, et al.
Publicado: (2023)

Systematic review and meta-analysis shows a specific micronutrient profile in people with Down Syndrome: Lower blood calcium, selenium and zinc, higher red blood cell copper and zinc, and higher salivary calcium and sodium
por: Saghazadeh, Amene, et al.
Publicado: (2017)

Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises
por: Basiri, Arefeh, et al.
Publicado: (2020)

Cardiovascular system is at higher risk of affecting by COVID-19
por: Nejadghaderi, Seyed Aria, et al.
Publicado: (2020)

SARS-CoV-2–A Tough Opponent for the Immune System
por: Nasab, Mahsa Golshani, et al.
Publicado: (2020)

Loneliness: An Immunometabolic Syndrome
por: Pourriyahi, Homa, et al.
Publicado: (2021)

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

The Effect of Influenza Vaccination on COVID-19 Morbidity, Severity and Mortality: Systematic Review and Meta-Analysis
por: ZEYNALI BUJANI, Meysam, et al.
Publicado: (2021)

Elevated interleukin-6 and adverse outcomes in COVID-19 patients: a meta-analysis based on adjusted effect estimates
por: Zhang, Peihua, et al.
Publicado: (2020)

Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis
por: Yin, Jing-Xian, et al.
Publicado: (2023)

Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis
por: Udomsinprasert, Wanvisa, et al.
Publicado: (2020)

Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19
por: Kappelmann, Nils, et al.
Publicado: (2021)

Elevated Levels of Pleiotropic Interleukin-6 (IL-6) and Interleukin-10 (IL-10) are Critically Involved With the Severity and Mortality of COVID-19: An Updated Longitudinal Meta-Analysis and Systematic Review on 147 Studies
por: Jafrin, Sarah, et al.
Publicado: (2022)

Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting
por: Sharifkashani, Sourena, et al.
Publicado: (2020)

Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis
por: Han, Qi, et al.
Publicado: (2020)

Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis
por: Hessami, Amirhossein, et al.
Publicado: (2021)

Elevated interleukin levels are associated with higher severity and mortality in COVID 19 – A systematic review, meta-analysis, and meta-regression
por: Yonas, Emir, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lif493uugb0as7iujmq6s94251